Author
Number of items: 13.
2013
  • Improving treatment of stroke through nanotechnology. (2013) F Nicholls, N Gorenkova, Ellen Bible, C Franco, David Y.S. Chau, Christos Tolias, Kevin Shakesheff, JL West and Michel Modo
    • 2012
  • Neo-vascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles. (2012) Ellen Bible, Omar Qutachi, David Y.S. Chau, Morgan R. Alexander, Kevin M. Shakesheff and Michel Modo
    • 2010
  • Combination of Injectable Multiple Growth Factor-Releasing Scaffolds and Cell Therapy as an Advanced Modality to Enhance Tissue Neovascularization. (2010) Jaimy Saif, Theresa M. Schwarz, David Y.S. Chau, James Henstock, Paramjit Sami, Simon F. Leicht, Patrick C. Hermann, Sonia Alcala, Francisca Mulero, Kevin M. Shakesheff, Christopher Heeschen and Alexandra Aicher
  • Transplantation of Human NSCs on VEGF-Releasing Microparticle Scaffolds in a Stroke Model. (2010) Ellen Bible, David Y.S. Chau, M. R. Alexander, J. Price, Kevin M. Shakesheff and Michel Modo
    • 2009
  • The effect of delivery via narrow-bore needles on mesenchymal cells. (2009) Kapil Agashi, David Y.S. Chau and Kevin M. Shakesheff
  • Life support systems for cell therapies. (2009) K. Agashi, David Y.S. Chau and Kevin M. Shakesheff
  • Attachment of stem cells to scaffold particles for intra-cerebral transplantation. (2009) Ellen Bible, David Y.S. Chau, Morgan R. Alexander, Jack Price, Kevin M. Shakesheff and Michel Modo
    • 2008
  • A biosynthetic bandage for corneal wound repair. (2008) Chayanin Pratoomsoot, Qingpu Hou, David Y.S. Chau, H. Tanioka, K. Hori, S. Kawasaki, S. Kinoshita, Patrick J. Tighe, Harminder Dua, Kevin M. Shakesheff and Felicity R. A. J. Rose
  • In situ gelling hydrogels incorporating microparticles as drug delivery carriers for regenerative medicine. (2008) Qingpu Hou, David Y.S. Chau, Chayanin Pratoomsoot, Patrick J. Tighe, Harminder S. Dua, Kevin M. Shakesheff and Felicity R. A. J. Rose
    • 2007
  • Collagen: Structure and modification for biomedical applications. (2007) David Y.S. Chau, Russell J. Collighan and Martin Griffin
    • 2006
  • Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. (2006) R. A. Jones, P. Kotsakis, T. S. Johnson, David Y.S. Chau, S. Ali, G. Melino and M. Griffin
    • 2005
  • The cellular response to transglutaminase-cross-linked collagen. (2005) David Y.S. Chau, R.J. Collighan, E.A.M. Verderio, V.L. Addy and M. Griffin
    • 2004
  • Artificial selection of high proliferating and apoptosis-resistant NS0 cells for industrial production systems. (2004) D Chau and M Al-Rubeai